Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TOREMIFENE CITRATE
(1997)
Small molecule
Estrogen receptor modulator
ORAL
Approved
Breast Neoplasms
TOREMIFENE CITRATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
2498Y783QT
Molecule Type:
Small molecule
Molecular Formula:
C32H36ClNO8
Molecular Weight:
598.09
AlogP:
6.22
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
SAMARIUM SM 153 LEXIDRONAM PENTASODIUM
(1997)
Small molecule
Unknown
Unknown
Approved
Unknown
SAMARIUM SM 153 LEXIDRONAM PENTASODIUM
×
Maximum Phase:
4
First Approval:
1997
UNII:
7389YR3OOV
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2Na5O12P4Sm
Molecular Weight:
695.93
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DOLASETRON
(1997)
Small molecule
Unknown
Unknown
Approved
Nausea
DOLASETRON
×
Maximum Phase:
4
First Approval:
1997
UNII:
82WI2L7Q6E
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3
Molecular Weight:
324.38
AlogP:
2.52
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
QUETIAPINE
(1997)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
QUETIAPINE
×
Maximum Phase:
4
First Approval:
1997
UNII:
BGL0JSY5SI
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O2S
Molecular Weight:
383.52
AlogP:
2.86
PSA:
48.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FEPRAZONE
(1997)
Small molecule
Unknown
Unknown
Approved
Arthralgia; Myalgia; Rheumatic Diseases
FEPRAZONE
×
Maximum Phase:
4
First Approval:
1997
UNII:
7BVX6J0CGR
Molecule Type:
Small molecule
Molecular Formula:
C20H20N2O2
Molecular Weight:
320.39
AlogP:
3.95
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NELFINAVIR MESYLATE
(1997)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections
NELFINAVIR MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
98D603VP8V
Molecule Type:
Small molecule
Molecular Formula:
C33H49N3O7S2
Molecular Weight:
663.9
AlogP:
4.75
PSA:
101.9
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ROPINIROLE
(1997)
Small molecule
Unknown
Unknown
Approved
Parkinson Disease
ROPINIROLE
×
Maximum Phase:
4
First Approval:
1997
UNII:
030PYR8953
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O
Molecular Weight:
260.38
AlogP:
2.85
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ANAGRELIDE
(1997)
Small molecule
Unknown
Unknown
Approved
Neoplasms
ANAGRELIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
K9X45X0051
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2N3O
Molecular Weight:
256.09
AlogP:
1.93
PSA:
44.7
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ROPINIROLE HYDROCHLORIDE
(1997)
Small molecule
D2-like dopamine receptor agonist
ORAL
Approved
Parkinson Disease; Restless Legs Syndrome
ROPINIROLE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
D7ZD41RZI9
Molecule Type:
Small molecule
Molecular Formula:
C16H25ClN2O
Molecular Weight:
296.84
AlogP:
2.85
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
7.0
Source:
EPROSARTAN MESYLATE
(1997)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Hypertension
EPROSARTAN MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
8N2L1NX8S3
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O7S2
Molecular Weight:
520.63
AlogP:
4.74
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TAZAROTENE
(1997)
Small molecule
Retinoic acid receptor agonist
Unknown
Approved
Acne Vulgaris; Hypopigmentation; Lentigo; Psoriasis
TAZAROTENE
×
Maximum Phase:
4
First Approval:
1997
UNII:
81BDR9Y8PS
Molecule Type:
Small molecule
Molecular Formula:
C21H21NO2S
Molecular Weight:
351.47
AlogP:
4.43
PSA:
39.19
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TAMSULOSIN
(1997)
Small molecule
Unknown
Unknown
Approved
Prostatic Hyperplasia
TAMSULOSIN
×
Maximum Phase:
4
First Approval:
1997
UNII:
G3P28OML5I
Molecule Type:
Small molecule
Molecular Formula:
C20H28N2O5S
Molecular Weight:
408.52
AlogP:
2.34
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ALATROFLOXACIN
(1997)
Small molecule
Unknown
Unknown
Approved
Unknown
ALATROFLOXACIN
×
Maximum Phase:
4
First Approval:
1997
UNII:
7QVV6I50DT
Molecule Type:
Small molecule
Molecular Formula:
C26H25F3N6O5
Molecular Weight:
558.52
AlogP:
0.9
PSA:
159.65
HBD:
4.0
HBA:
#RotB:
7.0
Source:
FENOLDOPAM MESYLATE
(1997)
Small molecule
Dopamine D1 receptor agonist
Unknown
Approved
Hypertension
FENOLDOPAM MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
HA3R0MY016
Molecule Type:
Small molecule
Molecular Formula:
C17H20ClNO6S
Molecular Weight:
401.87
AlogP:
2.73
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
EPROSARTAN
(1997)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
EPROSARTAN
×
Maximum Phase:
4
First Approval:
1997
UNII:
2KH13Z0S0Y
Molecule Type:
Small molecule
Molecular Formula:
C23H24N2O4S
Molecular Weight:
424.52
AlogP:
4.74
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
10.0
Source:
CLOPIDOGREL
(1997)
Small molecule
Unknown
Unknown
Approved
Thrombosis
CLOPIDOGREL
×
Maximum Phase:
4
First Approval:
1997
UNII:
A74586SNO7
Molecule Type:
Small molecule
Molecular Formula:
C16H16ClNO2S
Molecular Weight:
321.83
AlogP:
3.67
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TALC
(1997)
Small molecule
Unknown
INTRAPLEURAL
Approved
Pleural Effusion
TALC
×
Maximum Phase:
4
First Approval:
1997
UNII:
7SEV7J4R1U
Molecule Type:
Small molecule
Molecular Formula:
Mg3O11Si4
Molecular Weight:
361.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRICLOSAN
(1997)
Small molecule
Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor
Unknown
Approved
Unknown
TRICLOSAN
×
Maximum Phase:
4
First Approval:
1997
UNII:
4NM5039Y5X
Molecule Type:
Small molecule
Molecular Formula:
C12H7Cl3O2
Molecular Weight:
289.55
AlogP:
5.14
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MODAFINIL
(1998)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
MODAFINIL
×
Maximum Phase:
4
First Approval:
1998
UNII:
R3UK8X3U3D
Molecule Type:
Small molecule
Molecular Formula:
C15H15NO2S
Molecular Weight:
273.36
AlogP:
2.01
PSA:
60.16
HBD:
1.0
HBA:
#RotB:
5.0
Source:
NARATRIPTAN
(1998)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
NARATRIPTAN
×
Maximum Phase:
4
First Approval:
1998
UNII:
QX3KXL1ZA2
Molecule Type:
Small molecule
Molecular Formula:
C17H25N3O2S
Molecular Weight:
335.47
AlogP:
2.07
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MONTELUKAST SODIUM
(1998)
Small molecule
Cysteinyl leukotriene receptor 1 antagonist
ORAL
Approved
Asthma; Asthma, Exercise-Induced; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
MONTELUKAST SODIUM
×
Maximum Phase:
4
First Approval:
1998
UNII:
U1O3J18SFL
Molecule Type:
Small molecule
Molecular Formula:
C35H35ClNNaO3S
Molecular Weight:
608.18
AlogP:
8.95
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ABACAVIR SULFATE
(1998)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections
ABACAVIR SULFATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
J220T4J9Q2
Molecule Type:
Small molecule
Molecular Formula:
C28H38N12O6S
Molecular Weight:
670.76
AlogP:
1.09
PSA:
101.88
HBD:
3.0
HBA:
#RotB:
4.0
Source:
RIZATRIPTAN BENZOATE
(1998)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
RIZATRIPTAN BENZOATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
WR978S7QHH
Molecule Type:
Small molecule
Molecular Formula:
C22H25N5O2
Molecular Weight:
391.48
AlogP:
1.91
PSA:
49.74
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CITALOPRAM HYDROBROMIDE
(1998)
Small molecule
Serotonin transporter inhibitor
Unknown
Approved
Depressive Disorder; Depressive Disorder, Major
CITALOPRAM HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
I1E9D14F36
Molecule Type:
Small molecule
Molecular Formula:
C20H22BrFN2O
Molecular Weight:
405.31
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MONTELUKAST
(1998)
Small molecule
Unknown
Unknown
Approved
Asthma; Asthma, Exercise-Induced; Lung Diseases, Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal
MONTELUKAST
×
Maximum Phase:
4
First Approval:
1998
UNII:
MHM278SD3E
Molecule Type:
Small molecule
Molecular Formula:
C35H36ClNO3S
Molecular Weight:
586.2
AlogP:
8.95
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
12.0
Source:
EFAVIRENZ
(1998)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections; Infections; Virus Diseases
EFAVIRENZ
×
Maximum Phase:
4
First Approval:
1998
UNII:
JE6H2O27P8
Molecule Type:
Small molecule
Molecular Formula:
C14H9ClF3NO2
Molecular Weight:
315.68
AlogP:
4.07
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CAPECITABINE
(1998)
Small molecule
DNA inhibitor
ORAL
Approved
Breast Neoplasms; Colonic Neoplasms; Neoplasms
CAPECITABINE
×
Maximum Phase:
4
First Approval:
1998
UNII:
6804DJ8Z9U
Molecule Type:
Small molecule
Molecular Formula:
C15H22FN3O6
Molecular Weight:
359.35
AlogP:
0.76
PSA:
122.91
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TIROFIBAN HYDROCHLORIDE
(1998)
Small molecule
Integrin alpha-IIb/beta-3 inhibitor
INJECTION
Approved
Myocardial Infarction
TIROFIBAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
6H925F8O5J
Molecule Type:
Small molecule
Molecular Formula:
C22H39ClN2O6S
Molecular Weight:
495.08
AlogP:
2.95
PSA:
104.73
HBD:
3.0
HBA:
#RotB:
14.0
Source:
BRINZOLAMIDE
(1998)
Small molecule
Carbonic anhydrase II inhibitor
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
BRINZOLAMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
9451Z89515
Molecule Type:
Small molecule
Molecular Formula:
C12H21N3O5S3
Molecular Weight:
383.52
AlogP:
0.09
PSA:
118.8
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
(1998)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
INJECTION
Approved
Unknown
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
UXH81S8ZVB
Molecule Type:
Small molecule
Molecular Formula:
C23H32ClNO7
Molecular Weight:
469.96
AlogP:
2.52
PSA:
94.53
HBD:
1.0
HBA:
#RotB:
9.0
Source:
RISEDRONATE SODIUM
(1998)
Small molecule
Farnesyl diphosphate synthase inhibitor
ORAL
Approved
Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal
RISEDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
1998
UNII:
OFG5EXG60L
Molecule Type:
Small molecule
Molecular Formula:
C7H10NNaO7P2
Molecular Weight:
305.1
AlogP:
-0.37
PSA:
148.18
HBD:
5.0
HBA:
#RotB:
4.0
Source:
VALRUBICIN
(1998)
Small molecule
DNA inhibitor
INTRAVESICAL
Approved
Carcinoma; Neoplasms
VALRUBICIN
×
Maximum Phase:
4
First Approval:
1998
UNII:
2C6NUM6878
Molecule Type:
Small molecule
Molecular Formula:
C34H36F3NO13
Molecular Weight:
723.65
AlogP:
2.46
PSA:
215.22
HBD:
5.0
HBA:
#RotB:
10.0
Source:
SILDENAFIL
(1998)
Small molecule
Unknown
Unknown
Approved
Erectile Dysfunction
SILDENAFIL
×
Maximum Phase:
4
First Approval:
1998
UNII:
3M7OB98Y7H
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6O4S
Molecular Weight:
474.59
AlogP:
1.61
PSA:
113.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LEFLUNOMIDE
(1998)
Small molecule
Dihydroorotate dehydrogenase inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases; Multiple Sclerosis
LEFLUNOMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
G162GK9U4W
Molecule Type:
Small molecule
Molecular Formula:
C12H9F3N2O2
Molecular Weight:
270.21
AlogP:
3.25
PSA:
55.13
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TOLCAPONE
(1998)
Small molecule
Catechol O-methyltransferase inhibitor
ORAL
Approved
Liver Failure; Parkinson Disease
TOLCAPONE
×
Maximum Phase:
4
First Approval:
1998
UNII:
CIF6334OLY
Molecule Type:
Small molecule
Molecular Formula:
C14H11NO5
Molecular Weight:
273.24
AlogP:
2.55
PSA:
100.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SEVELAMER HYDROCHLORIDE
(1998)
Small molecule
Phosphate sequestering agent
ORAL
Approved
Unknown
SEVELAMER HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
GLS2PGI8QG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
47
48
49
50
51
52
53
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA